Intestinal epithelial cell surface glycoconjugates

Intestinal epithelial cells (IECs) and their associated surface glycoconjugates constitute the primary interface between the host and the luminal environment of the gut [Glycobiology, 4th ed.]. This complex layer, often referred to as the glycocalyx, consists of glycoproteins, glycolipids, and mucins that provide a physical and chemical barrier against pathogens and toxins while facilitating the absorption of nutrients [Nature Reviews Microbiology, 2009]. These glycoconjugates serve as critical docking sites for both beneficial commensal bacteria and harmful pathogens, such as Vibrio cholerae and various strains of Escherichia coli [JBC, 2012]. In pathological states like inflammatory bowel disease (IBD) or colorectal cancer, the glycosylation patterns on these cells are frequently altered, contributing to disease progression and barrier failure [Advanced Drug Delivery Reviews, 2005]. While specific components of this system are targeted by toxins and experimental lectin-based therapies, the ensemble itself is a broad biological structure rather than a single druggable molecular target [StatPearls].

Other names

Intestinal glycocalyxIEC surface glycansBrush border glycoconjugatesMucosal glycoconjugates

Binding to carbohydrate moieties or proteins on the intestinal epithelial surface to provide physical protection, modulate pathogen adhesion, or facilitate localized drug delivery [Nature Reviews Microbiology, 2009; Advanced Drug Delivery Reviews, 2005].